APW
PFE icon

Alliance Private Wealth’s Pfizer PFE Stock Holding History

Alliance Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Sell
35,965
-2,100
-6% -$54.9K 0.3% 63
2026
Q1 		$1.07M Buy
38,065
+1,082
+3% +$28.8K 0.38% 55
2025
Q4 		$953K Buy
+36,983
New +$933K 0.33% 62

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Alliance Private Wealth's PFE Position: Q2 2026 in Review

Alliance Private Wealth reduced its Pfizer (PFE) stake by 5.5% in Q2 2026, selling an estimated $54.9K and leaving 35,965 shares worth $866K. The position accounts for 0.3% of the portfolio, ranked #63.

Alliance Private Wealth first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.07M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Alliance Private Wealth held 35,965 shares of Pfizer worth $866K as of Q2 2026.
  • Alliance Private Wealth sold 2,100 Pfizer shares in Q2 2026, an estimated $54.9K.
  • Pfizer made up 0.3% of Alliance Private Wealth's portfolio in Q2 2026, its #63 holding.
  • Alliance Private Wealth first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Alliance Private Wealth's Pfizer position peaked at $1.07M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Alliance Private Wealth's 13F filing for Q2 2026, filed 9 Jul 2026.